Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.57 USD | +0.29% | -0.18% | +4.36% |
Evolution of the average Target Price on Halozyme Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Halozyme Therapeutics, Inc.
HC Wainwright | |
Goldman Sachs | |
Morgan Stanley | |
Piper Sandler | |
Berenberg Bank | |
Wells Fargo Securities | |
SVB Securities LLC | |
JPMorgan Chase | |
JMP Securities | |
Benchmark Company | |
SVB Leerink | |
Evercore ISI | |
Benchmark Capital |
EPS Revisions
- Stock Market
- Equities
- HALO Stock
- Consensus Halozyme Therapeutics, Inc.